An AI-first biotechnology company in San Diego, designing first-in-class small molecules and predicting their safety on one end-to-end platform.
Model Medicines
Released March 25, 2025
Ames mutagenicity prediction conditioned on bacterial tester strain and S9 metabolic activation, holding sensitivity on chemically novel compounds.